Baseline serum glycoprotein acetylation predicts early but not late relapse after infliximab withdrawal in Crohn's disease: metabolomic analysis of the STORI and SPARE trials.
Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.